Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLANET II: Rosuvastatin vs Atorvastatin in Proteinuria
NCT00296400Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2006
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
A Phase 2 trial of rosuvastatin in hypercholesterolemia, sponsored by AstraZeneca. Started Feb 2006; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00296400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296400.